Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Advanced Solid Tumors 3Solid Tumor 1Patients With Advanced or Metastatic Solid Tumors 1HER2-positive 1

Interventions

Injections 27Carboplatin 18Docetaxel 14pembrolizumab 13Paclitaxel 12Bevacizumab 10durvalumab 8Nivolumab 8Cisplatin 8Fluorouracil 7Pemetrexed 6Oxaliplatin 6Leucovorin 6trifluridine tipiracil drug combination 5toripalimab 5tislelizumab 5linifanib 5Capecitabine 5zimberelimab 4talazoparib 4olaparib 4fludarabine 4Panobinostat 4Itraconazole 4Irinotecan 4Gemcitabine 4Everolimus 4tremelimumab 3sotorasib 3sintilimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Advanced Solid Tumors × S 1 (combination) × Other solid neoplasm × Clear all
NCT02454062 2024-09-04

A Trial of TAS-114 in Combination With S-1

Taiho Oncology, Inc.

Phase 1 Completed
120 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01610479 2017-08-04

A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors

Taiho Pharmaceutical Co., Ltd.

Phase 1 Completed
120 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01128998 2015-10-19

Sorafenib Plus S-1 in Advanced Solid Tumors

National Health Research Institutes, Taiwan

Phase 1 Completed
30 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡